[{"NetIncomeLossConverted_2_Q2_USD":12475000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":2674000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":2671600000.0,"CommonStockSharesConverted_0_Q2_shares":3119843000.0,"Assets_0_Q2_USD":176440000000.0,"RevenuesConverted_1_Q2_USD":23312000000.0,"RevenuesConverted_2_Q2_USD":45633000000.0,"EarningsPerShareDiluted_1_Q2_USD":2.35,"EarningsPerShareDiluted_2_Q2_USD":4.67,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":9388000000.0,"CommonStockDividendsPerShareCashPaid_1_Q2_USD":1.06,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":2.07,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":2632000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":2632500000.0,"StockholdersEquityConverted_0_Q2_USD":69580000000.0,"NetIncomeLossConverted_1_Q2_USD":6278000000.0,"EarningsPerShareBasic_1_Q2_USD":2.38,"EarningsPerShareBasic_2_Q2_USD":4.74,"Ticker":"JNJ","CIK":"200406","name":"JOHNSON & JOHNSON","OfficialName":"Johnson & Johnson Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"481430000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210729"}]